Dostarlimab and Cobolimab in Advanced Cervical Cancer

Running, not enrolling · Phase 2

Conditions studied: Cervical Cancer, Advanced Cervical Carcinoma, Metastatic Cervical Cancer, Metastatic Cervical Carcinoma, Recurrent Cervical Carcinoma

In brief

This research is being done to determine how effective dostarlimab in combination with cobolimab is in metastatic or recurrent cervical cancer.

Key facts

Study ID

NCT06238635

Run by

Meghan Shea

People needed

66

Starts

2024-03-11

Expected to finish

2027-07-15

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.